Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2007
10/24/2007CN101057695A Method for preparing nutrition supplementing beverage for eye
10/24/2007CN101057694A Method for preparing eye-protecting beverage
10/24/2007CN101057599A Preparation method for wolfberry health food
10/24/2007CN100344648C Cyclosporine analogue mixtures and their use as immunomodulating agents
10/24/2007CN100344616C Compounds for the treatment of metabolic disorders
10/24/2007CN100344240C Nutrient food capable of preventing cataract and muscae volitantes and its making process
10/23/2007US7285683 Bicyclic and tricyclic cannabinoids
10/23/2007US7285680 β-alanine derivatives and the use thereof
10/23/2007US7285664 Heterocyclic or benzenic derivatives of lipoic acid, their preparation and their use as medicaments
10/23/2007US7285635 Reducing the antigenicity of a proteinaceous compound while maintaining the compound's biological activity
10/23/2007US7285549 Sulfamides and their use as endothelin receptor antagonists
10/23/2007US7285415 Differentiated cell population which generate glial cells for treating central nervous system traumas and disorders
10/18/2007WO2007118009A1 Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
10/18/2007WO2007117971A2 Ocular allergy treatments
10/18/2007WO2007117849A2 Use of inhibitors of jun n-terminal kinases to treat glaucoma
10/18/2007WO2007076473A3 Substituted pyrimidinyloxy ureas useful as inhibitors of protein kinases
10/18/2007US20070244172 Compounds for the treatment of metabolic disorders
10/18/2007US20070244171 Compounds for the treatment of metabolic disorders
10/18/2007US20070244141 Compounds for the treatment of metabolic disorders
10/18/2007US20070244068 2',3'-O-methylenestyryl-5'-alpha-(carboxymethylenephosphono)-N6-ethylaminocarbonyl-adenosine phosphate; modified mononucleoside phosphate by attaching degradation-resistant substituent on terminal phosphate; increase rate & total amount of mucin secretion; epithelial tissue, platelet aggregation diseases
10/18/2007US20070244062 Antisense Compounds Targeted to Connexins and Methods of Use Thereof
10/18/2007US20070244051 Side effect reduction; latanoprost; it is believed that TFF-peptides may be present during healing and other related processes in the eye
10/18/2007CA2648115A1 Ocular allergy treatments
10/18/2007CA2645171A1 Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
10/18/2007CA2644721A1 Use of inhibitors of jun n-terminal kinases to treat glaucoma
10/17/2007EP1845106A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
10/17/2007EP1845104A1 Par-2 agonist
10/17/2007EP1844787A1 Drugs for nerve cell regeneration
10/17/2007EP1844774A2 A pharmaceutical composition for angiotensin II-mediated diseases
10/17/2007EP1843791A1 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis
10/17/2007EP1843772A1 Intravenous formulations of pde-5 inhibitors
10/17/2007EP1843757A1 Phantom phenomena treatment
10/17/2007EP1474395B1 Nicotinamide derivates useful as p38 inhibitors
10/17/2007EP1064254B1 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
10/17/2007CN101056636A Aqueous ophthalmic suspension of crystalline rebamipide
10/17/2007CN101054344A Lipoxin A4 analogs
10/17/2007CN101053605A Traditional Chinese medicine powder for treating eye disease and protecting eyes
10/17/2007CN101053581A External applied medicine for treating tympanitis and preparation method thereof
10/17/2007CN101053561A Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis
10/17/2007CN100343255C Pyrazolo (1,5-a) pyrimidine derivative and nad(p)h oxidase inhibitor containing the same
10/16/2007US7282591 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/16/2007US7282511 Isatine derivatives with neurotrophic activity
10/16/2007US7282504 Kinase inhibitors
10/16/2007CA2419194C Cyclopentyl modulators of chemokine receptor activity
10/16/2007CA2327253C Sulfonamide-containing indole compounds
10/16/2007CA2248087C Improved vision through photodynamic therapy of the eye
10/11/2007WO2007115261A2 Drug delivery methods, structures, and compositions for nasolacrimal system
10/11/2007WO2007115259A2 Nasolacrimal drainage system implants for drug therapy
10/11/2007WO2007115020A2 Therapeutic prostaglandin compounds for the treatment of glaucoma
10/11/2007WO2007114315A1 Therapeutic agent for corneal/conjunctival disorder
10/11/2007WO2007114300A1 Preservative agent
10/11/2007WO2007112675A1 Vegf receptor fusion protein and use thereof
10/11/2007WO2007096859A3 Protection of the retina against laser injury by adnf peptides such as nap and sal
10/11/2007WO2007095561A3 Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
10/11/2007WO2007067807B1 Tetracyclines for treating ocular diseases and disorders
10/11/2007WO2000072801A3 Alpha v integrin receptor antagonists
10/11/2007US20070238768 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
10/11/2007US20070238766 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
10/11/2007US20070238763 Urea derivatives as integrin a4 antagonists
10/11/2007US20070238759 Novel Polymorph V of Torasemide
10/11/2007US20070238741 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine
10/11/2007US20070238735 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
10/11/2007US20070238659 Variants of vascular endothelial cell growth factors having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids
10/11/2007US20070237825 Reusable, nonbioadhesive, microporous hydrogel for hydrating and dehydrating dermatological surfaces prepared from hydroxyalkyl (meth)acrylate, a crosslinking agent, water, aliphatic alcohol (isopropanol), and a fibrous filler
10/11/2007DE60022050C5 Metabotrope glutamatrezeptorantagonisten zur behandlung von krankheiten des zentralen nervensystems Metabotropic glutamate receptor antagonists for treating diseases of the central nervous system
10/11/2007CA2648162A1 Prostaglandin analogues for the treatment of glaucoma or ocular hypertension
10/11/2007CA2647142A1 Vegf receptor fusion protein and use thereof
10/10/2007EP1841767A1 Pyrazolopyridines, their preparation and their medical use
10/10/2007EP1841435A1 Substance mixture
10/10/2007EP1525200B1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/10/2007EP1503746B1 Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders
10/10/2007EP1487829B1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain
10/10/2007EP1454897B1 Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
10/10/2007EP1404295B1 Sustained release drug delivery devices with coated drug cores
10/10/2007EP1396264B1 Relieving eye controlling function error
10/10/2007EP1354884B1 Cyclopenta[d]pyrazolo[1,5-a]pyrimidine compound as crf receptor antagonist
10/10/2007EP1347990B1 Peptides having inhibiting activity to nitric oxyde production
10/10/2007EP1261317B1 Methods and compositions for treating and preventing posterior segment ophthalmic disorders
10/10/2007EP1012271B1 Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
10/10/2007CN101052387A 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses
10/10/2007CN101049359A Eyedrop of Chinese traditional medicine for treating ophthalmic diseases, and preparation method
10/10/2007CN101049346A Medication for treating rhinitis and tympanitis, and preparation method
10/10/2007CN101049327A Application of gambogicacid in preparing medication for restraining angiogenesis
10/10/2007CN101049307A Matrine eye drip liquid, and producing method
10/10/2007CN101049287A Atropine eyewater in low concentration for restraining increase of degree of short sight and preparing method
10/10/2007CN100341989C Method for purifying tagetes oil-containing resin
10/10/2007CN100341899C Derivatives of new chitosan, preparation method, and application in use for making ophthalmic preparation
10/10/2007CN100341546C Pharmaceutical composition for resisting herpes simplex virus and its preparing process
10/10/2007CN100341498C Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
10/10/2007CN100341494C Eye wrinkle-removing film patch
10/09/2007US7279567 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
10/09/2007US7279493 cyanoiminopiperazines which inhibit vanilloid receptor 1 function in a cell
10/09/2007US7279490 Ophthalmic compositions for treating ocular hypertension
10/09/2007US7279489 Compounds and methods for modulation of estrogen receptors
10/09/2007US7279476 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device
10/09/2007US7279474 example compound: [7-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-(1-ethyl-propyl)amine; treatment of irritable bowel disease and inflammatory bowel disease; anxiety; depression
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279324 Nucleic acid encoding G-protein coupled receptor with modified DRY motif
10/04/2007WO2007112322A2 Indole compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity
10/04/2007WO2007111350A1 Agent for inhibition of angiogenesis or mesenchymal-type or amoeboid-type invasion of cancer cell
1 ... 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 ... 531